Literature DB >> 8842590

Biology and pathophysiology of leukotrienes.

C Denzlinger1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8842590     DOI: 10.1016/1040-8428(96)00205-3

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


× No keyword cloud information.
  7 in total

Review 1.  Pharmacological inhibition of leukotriene actions.

Authors:  F Engels; F P Nijkamp
Journal:  Pharm World Sci       Date:  1998-04

Review 2.  Tendon biomechanics and mechanobiology--a minireview of basic concepts and recent advancements.

Authors:  James H-C Wang; Qianping Guo; Bin Li
Journal:  J Hand Ther       Date:  2011-09-17       Impact factor: 1.950

3.  Leukotriene B4 at low dosage negates the catabolic effect of prostaglandin E2 in human patellar tendon fibroblasts.

Authors:  Bhavani P Thampatty; Hee-Jeong Im; James H-C Wang
Journal:  Gene       Date:  2006-02-20       Impact factor: 3.688

4.  Ultrafine particles affect the balance of endogenous pro- and anti-inflammatory lipid mediators in the lung: in-vitro and in-vivo studies.

Authors:  Ingrid Beck-Speier; Erwin Karg; Heidrun Behrendt; Tobias Stoeger; Francesca Alessandrini
Journal:  Part Fibre Toxicol       Date:  2012-07-18       Impact factor: 9.400

5.  Agglomerates of ultrafine particles of elemental carbon and TiO2 induce generation of lipid mediators in alveolar macrophages.

Authors:  I Beck-Speier; N Dayal; E Karg; K L Maier; C Roth; A Ziesenis; J Heyder
Journal:  Environ Health Perspect       Date:  2001-08       Impact factor: 9.031

Review 6.  Cysteinyl leukotrienes: multi-functional mediators in allergic rhinitis.

Authors:  M Peters-Golden; M M Gleason; A Togias
Journal:  Clin Exp Allergy       Date:  2006-06       Impact factor: 5.018

7.  Oxymetazoline inhibits and resolves inflammatory reactions in human neutrophils.

Authors:  Ingrid Beck-Speier; Barbara Oswald; Konrad L Maier; Erwin Karg; René Ramseger
Journal:  J Pharmacol Sci       Date:  2009-07       Impact factor: 3.337

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.